FALSE POSITIVE FINDINGS IN BREAST CANCER TOMOSYNTHESIS
Completed
- Conditions
- Breast Cancer Screening
- Registration Number
- NCT04259866
- Lead Sponsor
- "G Criscuoli" Hospital
- Brief Summary
To analyse false positives in breast cancer screening with tomosynthesis versus 2D mammography. The Avellino Breast Tomosynthesis Screening Trial is a observational population-based study that analyze souspicious findings in tomosynthesis slice images.
This study is based on two years screening and tomosynthesis was analzyed by two expert breast radiologists.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 4500
Inclusion Criteria
- breast cancer screening population
Exclusion Criteria
- previous cancer
- breast prostheses
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method recall rate 15 days
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie false positive findings in breast tomosynthesis compared to 2D mammography?
How does tomosynthesis improve lesion detection rates over standard 2D digital mammography in Avellino screening?
Which imaging biomarkers correlate with false positive recalls in digital breast tomosynthesis studies?
What are the management strategies for benign breast lesions identified through tomosynthesis screening?
How do false positive rates in NCT04259866 compare to other population-based breast cancer screening trials?
Trial Locations
- Locations (1)
Graziella Di Grezia
🇮🇹Avellino, Av, Italy
Graziella Di Grezia🇮🇹Avellino, Av, Italy